Neutrophil-to-Lymphocyte Ratio as a Predictor of PFS in mRCC Patients With Extrapulmonary Metastasis Treated With Targeted Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Impact of Neutrophil-to-Lymphocyte Ratio on Effects of Targeted Therapy for Metastatic Renal Cell Carcinoma Patients With Extrapulmonary Metastasis
Can Urol Assoc J 2017 May 01;11(5)E207-E214, J Teishima, S Ohara, K Sadahide, S Fujii, H Kitano, K Kobatake, S Shinmei, K Hieda, S Inoue, T Hayashi, K Mita, A MatsubaraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.